4Schultz MJ,Speelman P,Van der Poll T. Erythromycin inhibits Pseudomonas aeruginosa-induced tumour necrosis factor-alpha production in human whole blood[J].Journal of Antimicrobial Chemotherapy,2001,(02):275-278.
6Macleod CM,Hamid QA,Cameron L. Anti-inflammatory activity of clarithromycin in adults with chronically inflamed sinus mucosa[J].Advances in Therapy,2001,(02):75-82.
7Tagaya E,Tamaoki J,Kondo M. Effect of a short course of clarithromycin therapy on sputum production in patients with chronic airway hypersecretion[J].Chest,2002,(01):213-218.
5Labro MT. Cefodizime as a biological response modifier:a review of its in-vitro, ex-vivo and in-vivo immunomodulatory properties[J]. J Antimicrob Chemother, 1990,26(Suppl C):37.
6Limbert M, Bartlett RR, Dicknette G, et al. Cefodizime, an aminothiazolyl cephalosporin. IV.Influence on the immune system [J]. J Antibiot, 1984,37(12):1719.
7Labro MT, Benna J. Compoxison of cefodizime with various cephalosporins for their indirect effect on the human neutrophil oxidative burst in vitro. [J].J Antimicrob Chemother,1990, 26 (Suppl C) : 495.
8Ritts RE. IN antibiotics and the immune system with special reference to cefodizime [M]. Hocchst Aktiengsellschaft, 1984:22.
9Wenisch C, Parschalk B, Hasenhundl M, et al. Effect of cefodizime and ceftriaxone on phagocytic function in patients with severe infection [J]. J Antimicrob Chemother, 1995,39 (3):672.
10Scheffer J, Knoller J, Cullmann W, et al. Effects of cefaclor, cefetamet and R040-6890 on inflammatory responses of human granulocytes[J]. J Antimicrob Chemother, 1992,30(1):57.
